Page 6 of 11, showing 50 records out of 506 total, starting on record 251, ending on 300
| Year(s) |
Title |
|
2006 |
International Society of Gynecological Endocrinology Symposium on “The role of androgens in female sexual function” – “Current knowledge of androgens in breast cancer”, Florence, March 2006. |
|
1987 |
International School of Pharmacology, Ettore Marjorana Centre for Scientific Culture, "The Role of the Adrenals in Human Prostate and Breast Cancer", Erice (March 1987) |
|
1987 |
International School of Pharmacology, Ettore Marjorana Centre for Scientific Culture, "The Mouse Shionogi Carcinoma: an Experimental Model of Androgen-¬Sensitive Cancer", Erice (March 1987) |
|
1987 |
International School of Pharmacology, Ettore Marjorana Centre for Scientific Culture, "The Human Mammary Carcinoma ZR-75-1: a Model for Human Breast Cancer", Erice (March 1987) |
|
1987 |
International School of Pharmacology, Ettore Marjorana Centre for Scientific Culture, "Properties and Mechanism of Action of Antiandrogens Erice (March 1987) |
|
1987 |
International School of Pharmacology, Ettore Marjorana Centre for Scientific Culture, "Clinical Studies Using Combination Therapy with an LHRH Agonist and Flutamide in Stages C and D Prostate Cancer", |
|
1989 |
International School of Pharmacology, Biology and Biochemistry of Normal and Cancer Cell Growth, "Breast Cancer Cells - In Vitro Studies", Erice, Italy (March 1989) |
|
2004 |
International Menopause Forum Tuohilampi, “The role of androgens for the female health and for the breast“, Vienne (June 2004) |
|
1983 |
International Meeting on Recent Progress in Opioid Research, "Opioid modulation of endocrine functions", Florence (October 1983) |
|
1986 |
International Meeting on Clinical and Pathological Advances in Breast Tumors, "Important Role of Adrenal Steroids in Breast Cancer", Pisa (April 1986) |
|
1997 |
International Health Foundation Workshop : Dehydroepiandrosterone : Role of DHEA », Bosch en Duin (December 1997) |
|
1997 |
International Health Foundation of DHEA, "Role of DHEA Transformation into Androgens and Estrogens in Peripheral Intracrine Tissues", Amsterdam (December 1997) |
|
1992 |
International Course on Biology and Biochemistry of Normal and Cancer Cell Growth - Growth Factor and Their Action in Cancer, "Molecular Biology of Steroidogenic Enzymes", Erice (January 1992) |
|
1992 |
International Course on Biology and Biochemistry of Normal and Cancer Cell Growth - Growth Factor and Their Action in Cancer, "Inhibitory Action of Androgens on Breast Cancer Cell Growth", Erice (Janu |
|
1992 |
International Course on Biology and Biochemistry of Normal and Cancer Cell Growth - Growth Factor and Their Action in Cancer, "Importance of Pure Antiandrogens", Erice (January 1992) |
|
1992 |
International Course on Biology and Biochemistry of Normal and Cancer Cell Growth - Growth Factor and Their Action in Cancer, "Endocrinology of Total Androgen Blockage: Role of Intracrinology", Erice |
|
1982 |
International Congress on Therapy in Andrology: Pharmacological, Surgical and Psychological Aspects, "Clinical Experience in the Use of LHRH Agonists", Pisa (June 1982) |
|
1979 |
International Congress on Prolactin, "Interactions of Hypothalamic and Peripheral Hormones in the Control of Prolactin Secretion", Taormina (November 1979) |
|
1988 |
International Congress on Advances in Management of Malignancies, "Maximal Androgen Blockade in Prostate Cancer: Today's Therapy of Choice and 5-Year Clinical Experience", Ascoli Picero (May 1988) |
|
1975 |
International Congress of French Medicine, "Role of Prostaglandins in the Control of Adenohypophyseal Hormone Secretion", Dakar, Senegal (December 1975) |
|
1993 |
International Conference on Molecular Endocrinology, Athens (October 1993) |
|
1991 |
International Conference on Growth Control in Breast Cancer: Basic and Clinical Aspects, "Androgenic Compounds: Potential Role in the Therapy of Breast Cancer and their Mechanism of action", Taormina |
|
1991 |
International Ares-Serono Symposium on A Molecular View of Steroid Biosynthesis and Metabolism, "Structure and Tissue-Specific Expression of Multiple Types of Human and Rat 3?-Hydroxysteroid Dehydroge |
|
2003 |
Institute of Biochemistry and Cell Biology (IBCB), Shanghai (November 2003) |
|
1983 |
III Pan American Congress of Andrology, "Combined Treatment with an LHRH Agonist and an Antiandrogen in Prostate Cancer: a Highly Promising New Treatment", Cartagena (January 1983) |
|
1981 |
II Pan American Congress of Andrology, Symposium on Inhibin, Mexico City (January 1981) |
|
1981 |
II Pan American Congress of Andrology, Symposium on Antifertility Effects of LHRH Agonists in the Male, Mexico City (January 1981) |
|
2006 |
Gunma University Urological meeting, “The key role of combined androgen blockade in prostate cancer”, Tagasaki, October 2006 |
|
1994 |
Guest Speaker, Canadian Workshop on Screening for Prostate Cancer, Québec City (February 1994) |
|
1993 |
Guest Speaker, Canadian Academy of Urological Surgeons, “Implications of Bill in Canadian Research: How to Get our Share in Urology?”, Montreal (June 1993) |
|
1979 |
Guest Lecturer, Annual Meeting of the Canadian Fertility Society, "Current Research in Reproduction", Val David (September 1979) |
|
1995 |
Guest Lecturer, 25th Annual Convention of the Philippine College of Physicians: "Clinical Applications of Intracrinology: Focus on Prostate and Breast Cancers", Manila (May 1995) |
|
1984 |
Guest Lecturer, 24th Annual Meeting of the European Society for Pediatric Endocrinology, "Clinical Use of Hypothalamic Releasing Hormones", Heidelberg (September 1984) |
|
1976 |
Gordon Research Conference, "Mechanism of Action of Hypothalamic Hor-mones", Santa Barbara (January 1976) |
|
1973 |
Gordon Conference on Mechanisms of Hormone Action, Meriden (August 1973) |
|
1972 |
Gordon Conference on Cyclic AMP, Meridien (June 1972) |
|
2003 |
Genome Canada-Genome Espana Meeting, “Atlas of Genomic Profiles of Steroid Action”, Madrid (January 2003) |
|
2003 |
Genome Canada Symposium, “Atlas of Genomic Profiles of Steroid Action Response in Health and in Immune-Related Disorders”, Toronto (September 2003) |
|
2003 |
FSD Expert Panel Meeting, “Physiology of Sex Steroid Hormones in Women”, Amsterdam (octobre 2003) |
|
1975 |
Friday-at-Four Lecture, Dalhousie University, Halifax (January 1975) |
|
2001 |
First World Congress – Update in Androgen Disorders, “Major Impact on Survival of Androgen Blockade in Localized Prostate Cancer”, Gubbio, Italy (September 2001) |
|
2002 |
First World Congress on Hormonal and Genetic Basis of Sexual Differentiation Disorders, Phoenix (May 2002) |
|
1989 |
First International Symposium on Steroid Formation, Degradation and Action in Peripheral Normal and Neoplastic Tissues, "Future Trends in Drug Development for the Therapy of Hormone-Sensitive Cancer", |
|
1992 |
First International Symposium on Prostate Cancer and Transrectal Ultrasound, “Transrectal Ultrasound Update on Combined Hormonal Therapy in Prostate Cancer”, Buenos Aires (October 1992) |
|
1992 |
First International Symposium on Prostate Cancer and Transrectal Ultrasound, “Prescreening with Serum Prostatic Specific Antigen (PSA) Identifies a High-Risk Population” Buenos Aires (October 1992) |
|
1994 |
First International Forum on Prostate Cancer, “Endocrine Downstaging of Localized Disease”, Cambridge, UK (April 1994) |
|
1995 |
Fifth International Prostate Cancer Update, “The Québec Prostate Cancer Screening Study: the Diagnosis of Advanced Prostate Cancer can be Practically Eliminated”, Beaver Creek, Colorado (February 1995 |
|
1995 |
Fifth International Prostate Cancer Update, "Combined Androgen Blockade in Prostate Cancer", Beaver Creek, Colorado (February 1995) |
|
1982 |
Fertility Symposium, "The Possible Application of Man-Made Analogues of Luteinizing Hormone-Releasing Hormone in Male and Female Contraception", London, UK (October 1982) |
|
1997 |
European School of Oncology, Cancer of the Prostate, « Le dépistage », Nice (December 1997) |